EF5 PET OF TUMOR HYPOXIA: A PREDICTIVE IMAGING BIOMARKER OF RESPONSE TO STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) FOR EARLY LUNG CANCER
$498,694FY2012Department of DefenseDOD
The Leland Stanford Junior University
The Leland Stanford Junior University